Francesca Musumeci
Università degli Studi di Genova
H-index: 24
Europe-Italy
Top articles of Francesca Musumeci
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling | Molecules | Giancarlo Grossi Naomi Scarano Francesca Musumeci Michele Tonelli Evgeny Kanov | 2024/4/11 |
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment | Drug Development Research | Chiara Vagaggini Debora Petroni Ilaria D'Agostino Federica Poggialini Chiara Cavallini | 2024/2 |
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment | Davide Frumento Giancarlo Grossi Marta Falesiedi Francesca Musumeci Anna Carbone | 2024/1/23 | |
Inhibition of serum-and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models | Fluids and Barriers of the CNS | Alexandra Hochstetler Hillary Smith Makenna Reed Louise Hulme Paul Territo | 2023/8/18 |
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor | Journal of medicinal chemistry | Andrew J Culshaw Stuart Bevan Martin Christiansen Prafula Copp Andrew Davis | 2006/1/26 |
Virtual Screening Combined with Enzymatic Assays to Guide the Discovery of Novel SIRT2 Inhibitors | International Journal of Molecular Sciences | Naomi Scarano Elena Abbotto Francesca Musumeci Annalisa Salis Chiara Brullo | 2023/5/27 |
New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists | Pharmaceutics | Naomi Scarano Francesco Di Palma Nicola Origlia Francesca Musumeci Silvia Schenone | 2023/12/12 |
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against … | Pharmaceutics | Federica Poggialini Chiara Vagaggini Annalaura Brai Claudia Pasqualini Emmanuele Crespan | 2023/1/30 |
Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies | Pharmaceuticals | Federica Poggialini Chiara Vagaggini Annalaura Brai Claudia Pasqualini Anna Carbone | 2023/10/27 |
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells | Pharmaceutics | Lorenzo Monteleone Barbara Marengo Francesca Musumeci Giancarlo Grossi Anna Carbone | 2022/7/1 |
Inhibition of SGK1 ameliorates ventriculomegaly in a genetic rat model via regulation of TRPV4 in the choroid plexus | The FASEB Journal | Alexandra E Hochstetler Hillary Smith Makenna Reed Louise Hulme Nicola Perrotti | 2022/5 |
Novel pyrazolo [3, 4-d] pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment | Bioorganic Chemistry | Salvatore Di Maria Francesca Picarazzi Mattia Mori Annarita Cianciusi Anna Carbone | 2022/11/1 |
Synthetic heterocyclic derivatives as kinase inhibitors tested for the treatment of neuroblastoma | Francesca Musumeci Annarita Cianciusi Ilaria D’Agostino Giancarlo Grossi Anna Carbone | 2021/11/23 | |
Insights into RNA-dependent RNA polymerase inhibitors as antiinfluenza virus agents | Ilaria Giacchello Francesca Musumeci Ilaria D’Agostino Chiara Greco Giancarlo Grossi | 2021/2/1 | |
Development of Pyrazolo[3,4-d]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme | ACS Medicinal Chemistry Letters | Chiara Greco Vincenzo Taresco Amanda K Pearce Catherine E Vasey Stuart Smith | 2020/2/13 |
Starch/poly (glycerol-adipate) nanocomposites: A novel oral drug delivery device | Coatings | Ambra Vestri Amanda K Pearce Robert Cavanagh Ioanna D Styliari Carlos Sanders | 2020/2/1 |
Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors | Molecules | Chiara Greco Rosa Catania Dario Leonardo Balacco Vincenzo Taresco Francesca Musumeci | 2020/11/16 |
